Latest Issue

Volume 12 Issue 2

Paper of the Month

Early symptomatic response and mucosal healing with mesalazine rectal suspension therapy in active distal ulcerative colitis – additional results from two controlled studies

Sandborn WJ, Hanauer S, Lichtenstein GR et al.
Aliment Pharmacol Ther 2011;34:747–56. In this analysis of data from two previous clinical trials, the effect of mesalazine enemas in active distal ulcerative colitis was determined. Although the rates of mucosal healing at 6 weeks differed between the two studies, both demonstrated significant rapid improvements in rectal bleeding with mesalazine enemas, with a median time to cessation of rectal bleeding of 8 days.
» Read an expert review of this paper

Webcast

Ferric carboxymaltose for iron deficiency anemia in IBD
Dr Rayko Estatiev (Medical University of Vienna, Vienna, Austria) discusses the FERGIcor trial of ferric carboxymaltose for iron deficiency anemia in IBD

Latest news

  • Home
  • Home
  • Home
  • Home
  • Home
  • Home

READER POLL

IBD poll 2
Which IBD patients do you consider to be most at risk of lymphoma?






Powered by NetPolls

READER SURVEY

SUBMIT AN ARTICLE

OTHER REMEDICA JOURNALS

COMPASS PUBMED SEARCH

Enter your search terms below to search pubmed for articles